Skip to main content
Premium Trial:

Request an Annual Quote

GenMark Gets FDA OK for Respiratory Virus Panel

NEW YORK (GenomeWeb News) – GenMark Diagnostics has received US Food and Drug Administration 510(k) clearance for its eSensor Respiratory Virus Panel.

The test simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illness. According to GenMark, it has the "potential to significantly improve patient care by delivering superior co-infection detection, distinguishing rhinovirus from enteroviruses and identifying clinically relevant adenoviruses."

The test runs on the firm's eSensor XT-8 system.

The RVP test is the fourth FDA-cleared molecular diagnostic for GenMark, joining the firm's cystic fibrosis genotyping test, warfarin sensitivity test, and thrombophilia risk test. The Carlsbad, Calif.-based firm also is developing a hepatitis C virus test and a 2C19 test.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.